MitoSense
Operator of a medical research company intended to develop treatments for neurodegenerative diseases. The company utilizes mitochondrial organelle transplantation (MOT) technology to replenish the mit...
Valuation
$0
Share Price
N/A
Total Raised
$4.4M
Last Round
N/A